$9.03
0.56% today
NYSE, Nov 04, 09:13 pm CET
ISIN
US37954A2042
Symbol
GMRE
Sector
Industry

Global Medical REIT Inc Target price 2024 - Analyst rating & recommendation

Global Medical REIT Inc Classifications & Recommendation:

Buy
60%
Hold
40%

Global Medical REIT Inc Price Target

Target Price $10.91
Price $8.98
Potential
Number of Estimates 8
8 Analysts have issued a price target Global Medical REIT Inc 2025 . The average Global Medical REIT Inc target price is $10.91. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 6 Analysts recommend Global Medical REIT Inc to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Global Medical REIT Inc stock has an average upside potential 2025 of . Most analysts recommend the Global Medical REIT Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 156.65 139.27
14.31% 11.10%
EBITDA Margin 71.29% 68.55%
2.90% 3.85%
Net Margin 9.63% -1.41%
0.60% 114.64%

8 Analysts have issued a sales forecast Global Medical REIT Inc 2024 . The average Global Medical REIT Inc sales estimate is

$139m
Unlock
. This is
10.43% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$140m 9.96%
Unlock
, the lowest is
$138m 11.23%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $157m 14.31%
2024
$139m 11.10%
Unlock
2025
$145m 4.25%
Unlock
2026
$151m 3.69%
Unlock
2027
$155m 3.22%
Unlock
2028
$161m 3.35%
Unlock

6 Analysts have issued an Global Medical REIT Inc EBITDA forecast 2024. The average Global Medical REIT Inc EBITDA estimate is

$95.5m
Unlock
. This is
13.14% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$99.1m 9.84%
Unlock
, the lowest is
$90.8m 17.36%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $112m 17.62%
2024
$95.5m 14.51%
Unlock
2025
$104m 8.84%
Unlock
2026
$113m 9.20%
Unlock
2027
$115m 1.53%
Unlock
2028
$120m 3.73%
Unlock

EBITDA Margin

2023 71.29% 2.90%
2024
68.55% 3.85%
Unlock
2025
71.57% 4.41%
Unlock
2026
75.37% 5.31%
Unlock
2027
74.13% 1.65%
Unlock
2028
74.41% 0.38%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 0.23 -0.03
15.00% 113.04%
P/E negative
EV/Sales 9.35

Based on analysts' sales estimates for 2024, the Global Medical REIT Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.38 1.21%
2024
9.35 11.62%
Unlock
2025
8.97 4.08%
Unlock
2026
8.65 3.56%
Unlock
2027
8.38 3.12%
Unlock
2028
8.11 3.24%
Unlock

P/S ratio

Current 3.79 4.78%
2024
4.23 11.64%
Unlock
2025
4.06 4.08%
Unlock
2026
3.91 3.56%
Unlock
2027
3.79 3.12%
Unlock
2028
3.67 3.24%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today